Hepatitis A D006506

Diseases [C] » Infections [C01] » Virus Diseases » Hepatitis, Viral, Human » Hepatitis A

Diseases [C] » Digestive System Diseases [C06] » Liver Diseases » Hepatitis » Hepatitis, Viral, Human » Hepatitis A

Description

INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water.   MeSH

Phase 4 Indicated Drugs (138)

Phase 3 Indicated Drugs (90)

Phase 2 Indicated Drugs (175)


Organization Involved with Phase 4 Indications (264)

Aarhus University

AbbVie

Ain Shams University

Alaska Native Tribal Health Consortium

American University of Beirut

Arizona State University

Asian-Pacific Alliance of Liver Disease, Beijing

Azad University

Baqiyatallah Medical Sciences University

Baylor University

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Bristol-Myers Squibb

British University In Egypt

Bukwang Pharmaceutical

Cairo University

Calmette Hospital

Cangene

Capital Medical University

Catholic University of Korea

Center For Hepatitis C, Atlanta, GA

Centers for Disease Control and Prevention (CDC)

Centre for Infectious Disease Research in Zambia (CIDRZ)

Chacha Nehru Bal Chikitsalaya, New Delhi

Chang Gung University

Changhua Christian Hospital

ChengChing Hospital

Chiangmai University

Chiayi Christian Hospital

Children's National Medical Center

China Medical University

China National Biotec Group Co., Ltd

Chinese Academy of Medical Sciences

Chinese University of Hong Kong

Chonbuk National University

Chong Kun Dang Pharmaceutical

Chongqing Medical University

Christian Medical College, Vellore, India

Chugai

Chungnam National University

Chung Shan Medical University

Columbia University

Community Research Initiative of New England

Cornell University

Crucell

Daewoong Pharmaceutical Co. LTD.

Dayanand Medical College

Department of Veteran Affairs

DIAGSERA

Dong-A Pharmaceutical

Dong-A University

Duke University

Erasmus University Rotterdam

Far Eastern Memorial Hospital

Federal University of Health Science of Porto Alegre

FGK Clinical Research GmbH

Foo Yin Hospital

Foundation for Liver Research

French National Agency for Research on AIDS and Viral Hepatitis

Fudan University

Gachon University

Georgetown University

Getz Pharma

Gilead Sciences

GlaxoSmithKline

Government of China

Government of France

Government of Norway

Government of Taiwan

Govind Ballabh Pant Institute of Postgraduate Medical Education and Research

Grifols

Guilin University

Hai Phong Medical University

Hanmi Pharmaceutical

Hanyang University

Harvard University

Henan Medical University

Hepatobiliary Disease Hospital of Jilin Province, Jilin, China

HIV-NAT Thai Red Cross AIDS Research Center

Hospital Universitario Fundación Alcorcón

Huazhong University

Humanity & Health Research Centre

Icahn School of Medicine at Mount Sinai

Id Care

IDEWE Occupational Health Services

IlDong Pharmaceutical Co Ltd

Indivior Inc.

Inje University

Instituto de Estudios de Ciencias de la Salud de Castilla y León (IECSCYL)

International Antiviral Therapy Evaluation Center (IATEC)

International Center for Diarrheal Disease Research

Iranian Blood Transfusion Research Center

Isfahan University

I-Shou University

Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd

Jiao Tong University

Johns Hopkins University

Kadmon

Kaohsiung Medical University

Keimyung University

King Abdul-Aziz University

King Faisal University

Konkuk University

Korea University

Kyungpook University

Leiden University

Liaocheng People's Hospital

Linyi People's Hospital

Liver Institute of Virginia

Louisiana State University

Luohe Central Hospital

Mayo Clinic

McMaster University

Medical University of Vienna

Melbourne Health

Merck

MinaPharm Pharmaceuticals

Nanhua Hospital

Nanjing Medical University

Nanyang Central Hospital

National Autonomous University of Mexico

National Cheng Kung University

National Guard Health Affairs

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute on Drug Abuse (NIDA)

National Institutes of Health (NIH)

National Taiwan University

New Discovery LLC

Ningxia Medical University

NORDynamIC Study Group

Norte Study Group

Novartis

Oregon Health and Science University

Oswaldo Cruz Foundation

Pacific Health Foundation

Paochien Hospital

Partners in Health

Peking University

People's Liberation Army of China

Pfizer

Pontificia Universidad Catolica de Chile

Postgraduate Institute of Medical Education and Research

Pusan National University Hospital

Qingdao Infectious Diseases Hospital

Qingdao University

Radboud University

Rajiv Gandhi University of Health Sciences

Region Skane

Research Foundation for Mental Hygiene, Inc.

Riyadh Military Hospital

Roche

Rush University

Rwanda Biomedical Center

Rwanda Military Hospital

RWTH Aachen University

Saarland University

Sanofi

Sapienza University of Rome

Schering-Plough

Second Military Medical University

Seoul National University

Services Hospital, Lahore

Services Institute of Medical Sciences, Pakistan

Shanghai Medical University

Shanghai University of Traditional Chinese Medicine

Shantha Biotechnics Limited

Shanxi Medical University

Shenzhen Kangtai Biological Products Co., LTD

Shineway Pharmaceutical Co.,Ltd

Sichuan University

Sinovac Biotech Co., Ltd

Sociedad Andaluza de Enfermedades Infecciosas

Southeast University

Southern Medical University

Stanford University

State University of New York

State University of New York, Syracuse

St. James's Hospital, Dublin

Sungkyunkwan University

Sun Yat-Sen University

Tai'an Central Hospital

Taichung Veterans General Hospital

Taipei Medical University

Taipei Veteran General hospital

Tanta University

The Fifth Hospital of Shijiazhuang

The Fifth People's Hospital of Suzhou

The Third Hospital of Qinhuangdao City

The Third People's Hospital of Taiyuan

The University of Hong Kong

Thomas Jefferson University

Tianjin University

Tongji University

Trinity College Dublin

Tulane University

Tung's Taiching MetroHarbor Hospital

Tzu Chi University

United States Army

Universidad Autonoma de Barcelona

Universidad Carlos III Madrid

University of Amsterdam

University of Barcelona

University of Bern

University of Bonn

University of British Columbia

University of Calgary

University of California, Los Angeles

University of California, San Diego

University of California, San Francisco

University of Cantabria

University of Catania

University of Chicago

University of Colorado, Denver

University of Copenhagen

University of Florida

University of Gothenburg

University of Helsinki

University of Kentucky

University of London

University of Malaga

University of Manitoba

University of Maryland

University of Miami

University of Michigan

University of Nebraska

University of New South Wales

University of Nimes

University of North Carolina at Chapel Hill

University of Nottingham

University of Oxford

University of Padova

University of Pennsylvania

University of Pittsburgh

University of Rwanda

University of Salamanca

University of Sao Paulo

University of Seville

University of South Carolina

University of South Florida

University of Tabriz

University of Tehran

University of Texas at Houston

University of the Witwatersrand

University of Toronto

University of Turin

University of Ulm

University of Ulsan

University of Valencia

University of Vermont

University of Vienna

University of Washington

University of Western Ontario

Vertex

ViiV Healthcare

Virginia Commonwealth University

Weifang People's Hospital

Wilhelminenspital der Stadt Wien

Yale University

Yassin Abdelghaffar Charity Center for Liver Disease and Research

Yassin Abdel Ghaffar Charity Center for Liver Disease and Research

Yeshiva University

Yonsei University

Zhejiang Hisun Pharmaceutical Co. Ltd.

Zhejiang University

Organization Involved with Phase 3 Indications (114)

Organization Involved with Phase 2 Indications (139)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.